{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T02:25:31Z","timestamp":1791685531638,"version":"4.3.4"},"reference-count":309,"publisher":"Frontiers Media SA","content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"DOI":"10.3389\/fneur.2015.00178","type":"journal-article","created":{"date-parts":[[2015,9,7]],"date-time":"2015-09-07T12:28:09Z","timestamp":1441628889000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":96,"title":["Cathepsin B is a New Drug Target for Traumatic Brain Injury Therapeutics: Evidence for E64d as a Promising Lead Drug Candidate"],"prefix":"10.3389","volume":"6","author":[{"given":"Gregory","family":"Hook","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Steven","family":"Jacobsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Grabstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Kindy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivian","family":"Hook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2015,9,2]]},"reference":[{"key":"B1","doi-asserted-by":"crossref","first-page":"341","DOI":"10.3233\/NRE-2007-22502","article-title":"The impact of traumatic brain injuries: a global perspective","volume":"22","author":"Hyder","year":"2007","journal-title":"NeuroRehabilitation"},{"key":"B2","doi-asserted-by":"crossref","DOI":"10.15620\/cdc.5571","volume-title":"Traumatic Brain Injury in the United States: Emergency Department visits, Hospitalizations, and Deaths","author":"Faul","year":"2010"},{"key":"B3","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1097\/00001199-200611000-00009","article-title":"Incidence of traumatic brain injury in the United States, 2003","volume":"21","author":"Rutland-Brown","year":"2006","journal-title":"J Head Trauma Rehabil"},{"key":"B4","first-page":"495","article-title":"Concussions among United States high school and collegiate athletes","volume":"42","author":"Gessel","year":"2007","journal-title":"J Athl Train"},{"key":"B5","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1097\/00001199-200609000-00004","article-title":"Military TBI during the Iraq and Afghanistan wars","volume":"21","author":"Warden","year":"2006","journal-title":"J Head Trauma Rehabil"},{"key":"B6","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1089\/neu.2008.0586","article-title":"Classification of traumatic brain injury for targeted therapies","volume":"25","author":"Saatman","year":"2008","journal-title":"J Neurotrauma"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1503\/cmaj.080282","article-title":"Traumatic brain injury: can the consequences be stopped?","volume":"178","author":"Park","year":"2008","journal-title":"CMAJ"},{"key":"B8","doi-asserted-by":"crossref","first-page":"287","DOI":"10.31887\/DCNS.2011.13.2\/tmcallister","article-title":"Neurobiological consequences of traumatic brain injury","volume":"13","author":"McAllister","year":"2011","journal-title":"Dialogues Clin Neurosci"},{"key":"B9","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1093\/bja\/aem131","article-title":"Pathophysiology of traumatic brain injury","volume":"99","author":"Werner","year":"2007","journal-title":"Br J Anaesth"},{"key":"B10","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/S0079-6123(06)61004-2","article-title":"Cellular and subcellular change evoked by diffuse traumatic brain injury: a complex web of change extending far beyond focal damage","volume":"161","author":"Farkas","year":"2007","journal-title":"Prog Brain Res"},{"key":"B11","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1001\/jamaneurol.2014.3558","article-title":"Inflammation and neuroprotection in traumatic brain injury","volume":"72","author":"Corps","year":"2015","journal-title":"JAMA Neurol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1089\/089771503767869971","article-title":"Microvascular basal lamina antigen loss after traumatic brain injury in the rat","volume":"20","author":"Muellner","year":"2003","journal-title":"J Neurotrauma"},{"key":"B13","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1097\/01.WCB.0000100045.07481.DE","article-title":"Defining ischemic burden after traumatic brain injury using 15O PET imaging of cerebral physiology","volume":"24","author":"Coles","year":"2004","journal-title":"J Cereb Blood Flow Metab"},{"key":"B14","first-page":"79","article-title":"Traumatic intracranial aneurysm formation following closed head injury","volume":"1","author":"Miley","year":"2008","journal-title":"J Vasc Interv Neurol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1016\/j.neuroscience.2004.06.046","article-title":"Edema and brain trauma","volume":"129","author":"Unterberg","year":"2004","journal-title":"Neuroscience"},{"key":"B16","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1001\/jama.300.6.711","article-title":"Prevalence of chronic pain after traumatic brain injury: a systematic review","volume":"300","author":"Nampiaparampil","year":"2008","journal-title":"JAMA"},{"key":"B17","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1111\/j.1524-4725.1983.tb00811.x","article-title":"Monitoring respirations for outpatient surgery","volume":"9","author":"Grande","year":"1983","journal-title":"J Dermatol Surg Oncol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/2046-4053-2-68","article-title":"Incidence, prevalence, and occurrence rate of infection among adults hospitalized after traumatic brain injury: study protocol for a systematic review and meta-analysis","volume":"2","author":"Scott","year":"2013","journal-title":"Syst Rev"},{"key":"B19","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1111\/j.1471-4159.1993.tb07437.x","article-title":"Traumatic brain injury-induced excitotoxicity assessed in a controlled cortical impact model","volume":"61","author":"Palmer","year":"1993","journal-title":"J Neurochem"},{"key":"B20","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1093\/aje\/kwm153","article-title":"Head injury and amyotrophic lateral sclerosis","volume":"166","author":"Chen","year":"2007","journal-title":"Am J Epidemiol"},{"issue":"6","key":"B21","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1002\/ana.24396","article-title":"Traumatic brain injury in later life increases risk for Parkinson\u2019s disease","volume":"77","author":"Gardner","year":"2015","journal-title":"Ann Neurol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1136\/jnnp.74.7.857","article-title":"Head injury as a risk factor for Alzheimer\u2019s disease: the evidence 10 years on; a partial replication","volume":"74","author":"Fleminger","year":"2003","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B23","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1056\/NEJM199801013380104","article-title":"A population-based study of seizures after traumatic brain injuries","volume":"338","author":"Annegers","year":"1998","journal-title":"N Engl J Med"},{"key":"B24","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1089\/neu.2011.1936","article-title":"Increased risk of multiple sclerosis after traumatic brain injury: a nationwide population-based study","volume":"29","author":"Kang","year":"2012","journal-title":"J Neurotrauma"},{"issue":"Pt B","key":"B25","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.mcn.2015.03.007","article-title":"Post-traumatic neurodegeneration and chronic traumatic encephalopathy","volume":"66","author":"Daneshvar","year":"2015","journal-title":"Mol Cell Neurosci"},{"key":"B26","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1089\/089771502753754037","article-title":"Clinical trials in head injury","volume":"19","author":"Narayan","year":"2002","journal-title":"J Neurotrauma"},{"key":"B27","doi-asserted-by":"publisher","first-page":"731","DOI":"10.2119\/2008-00050.Beauchamp","article-title":"Pharmacology of traumatic brain injury: where is the \u201cgolden bullet\u201d?","volume":"14","author":"Beauchamp","year":"2008","journal-title":"Mol Med"},{"key":"B28","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.1056\/NEJMoa1404304","article-title":"Very early administration of progesterone for acute traumatic brain injury","volume":"371","author":"Wright","year":"2014","journal-title":"N Engl J Med"},{"key":"B29","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1007\/s11606-011-1938-8","article-title":"Updated report on comparative effectiveness of ACE inhibitors, ARBs, and direct renin inhibitors for patients with essential hypertension: much more data, little new information","volume":"27","author":"Powers","year":"2012","journal-title":"J Gen Intern Med"},{"key":"B30","doi-asserted-by":"publisher","first-page":"299","DOI":"10.2147\/PPA.S65199","article-title":"Combination dolutegravir-abacavir-lamivudine in the management of HIV\/AIDS: clinical utility and patient considerations","volume":"9","author":"Cruciani","year":"2015","journal-title":"Patient Prefer Adherence"},{"key":"B31","doi-asserted-by":"publisher","first-page":"239","DOI":"10.2174\/156800911794519752","article-title":"Bortezomib as the first \u00adproteasome inhibitor anticancer drug: current status and future perspectives","volume":"11","author":"Chen","year":"2011","journal-title":"Curr Cancer Drug Targets"},{"key":"B32","doi-asserted-by":"publisher","first-page":"387","DOI":"10.2174\/138161207779313542","article-title":"Emerging roles of cysteine cathepsins in disease and their potential as drug targets","volume":"13","author":"Vasiljeva","year":"2007","journal-title":"Curr Pharm Des"},{"key":"B33","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1517\/14728222.2013.740461","article-title":"Cathepsin B as a cancer target","volume":"17","author":"Gondi","year":"2013","journal-title":"Expert Opin Ther Targets"},{"key":"B34","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.tips.2007.10.011","article-title":"Cysteine cathepsin proteases as pharmacological targets in cancer","volume":"29","author":"Palermo","year":"2008","journal-title":"Trends Pharmacol Sci"},{"key":"B35","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1515\/BC.2003.095","article-title":"Molecular regulation of human cathepsin B: implication in pathologies","volume":"384","author":"Yan","year":"2003","journal-title":"Biol Chem"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.4155\/fmc.14.73","article-title":"The current stage of cathepsin B inhibitors as potential anticancer agents","volume":"6","author":"Kos","year":"2014","journal-title":"Future Med Chem"},{"key":"B37","doi-asserted-by":"publisher","first-page":"G794","DOI":"10.1152\/ajpgi.00363.2001","article-title":"Cathepsin B inhibition prevents trypsinogen activation and reduces pancreatitis severity","volume":"283","author":"Van Acker","year":"2002","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1172\/JCI17740","article-title":"Cathepsin B inactivation attenuates hepatic injury and fibrosis during cholestasis","volume":"112","author":"Canbay","year":"2003","journal-title":"J Clin Invest"},{"key":"B39","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1006\/bbrc.2001.4787","article-title":"Significance of cathepsin B accumulation in synovial fluid of rheumatoid arthritis","volume":"283","author":"Hashimoto","year":"2001","journal-title":"Biochem Biophys Res Commun"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1093\/intimm\/dxh311","article-title":"Amelioration of experimental arthritis by a calpain-inhibitory compound: regulation of cytokine production by E-64-d in vivo and in vitro","volume":"17","author":"Yoshifuji","year":"2005","journal-title":"Int Immunol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1126\/science.1110656","article-title":"Endosomal proteolysis of the Ebola virus glycoprotein is necessary for infection","volume":"308","author":"Chandran","year":"2005","journal-title":"Science"},{"key":"B42","doi-asserted-by":"publisher","first-page":"5440","DOI":"10.4049\/jimmunol.1100790","article-title":"The NLRP3 inflammasome contributes to brain injury in pneumococcal meningitis and is activated through ATP-dependent lysosomal cathepsin B release","volume":"187","author":"Hoegen","year":"2011","journal-title":"J Immunol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1097\/QCO.0b013e328315cca9","article-title":"Development of protease inhibitors for protozoan infections","volume":"21","author":"McKerrow","year":"2008","journal-title":"Curr Opin Infect Dis"},{"key":"B44","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1586\/egh.11.6","article-title":"Apoptosis in nonalcoholic fatty liver disease: diagnostic and therapeutic implications","volume":"5","author":"Alkhouri","year":"2011","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"B45","first-page":"1128A","article-title":"Efficacy of a reversible cathepsin B inhibitor in a rodent model of liver fibrosis and human pharmacokinetic profile","volume":"52","author":"Holsinger","year":"2010","journal-title":"Hepatology"},{"key":"B46","doi-asserted-by":"publisher","first-page":"3932","DOI":"10.1128\/AAC.00436-07","article-title":"A cysteine protease inhibitor cures Chagas\u2019 disease in an immunodeficient-mouse model of infection","volume":"51","author":"Doyle","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"B47","doi-asserted-by":"crossref","DOI":"10.1007\/0-387-23101-3_4","article-title":"Proteases in traumatic brain injury","volume-title":"Proteases in the Brain","author":"Knoblach","year":"2005"},{"key":"B48","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1089\/neu.2013.2944","article-title":"The cysteine protease cathepsin B is a key drug target and cysteine protease inhibitors are potential therapeutics for traumatic brain injury","volume":"31","author":"Hook","year":"2014","journal-title":"J Neurotrauma"},{"issue":"2","key":"B49","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1089\/neu.2013.3019","article-title":"Pharmacotherapy of traumatic brain injury: state of the science and the road forward report of the Department of Defense Neurotrauma Pharmacology Workgroup","volume":"31","author":"Diaz-Arrastia","year":"2013","journal-title":"J Neurotrauma"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.3390\/ijms15011216","article-title":"Neuroprotective strategies for traumatic brain injury: improving clinical translation","volume":"15","author":"Kabadi","year":"2014","journal-title":"Int J Mol Sci"},{"key":"B51","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1186\/s13054-015-0887-8","article-title":"Neuroprotection in acute brain injury: an up-to-date review","volume":"19","author":"Stocchetti","year":"2015","journal-title":"Crit Care"},{"key":"B52","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0021-9258(18)73552-7","article-title":"On the proteolytic enzymes of animal tissues: beef spleen","volume":"130","author":"Fruton","year":"1939","journal-title":"J Biol Chem"},{"key":"B53","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0021-9258(18)51430-7","article-title":"One the proteolytic enzymes of beef spleen, beef kidney, and swine kidney. Classification of the cathepsins","volume":"138","author":"Fruton","year":"1941","journal-title":"J Biol Chem"},{"key":"B54","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/S0021-9258(18)55834-8","article-title":"On the proteolytic enzymes of animal tissues. X. Beef spleen cathepsin C","volume":"194","author":"Tallan","year":"1952","journal-title":"J Biol Chem"},{"key":"B55","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0021-9258(18)64818-5","article-title":"Purification and properties of beef spleen cathepsin B","volume":"226","author":"Greenbaum","year":"1957","journal-title":"J Biol Chem"},{"key":"B56","doi-asserted-by":"publisher","first-page":"3666","DOI":"10.1073\/pnas.80.12.3666","article-title":"Homology of amino acid sequences of rat liver cathepsins B and H with that of papain","volume":"80","author":"Takio","year":"1983","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B57","doi-asserted-by":"publisher","first-page":"7721","DOI":"10.1073\/pnas.83.20.7721","article-title":"Nucleotide and predicted amino acid sequences of cloned human and mouse preprocathepsin B cDNAs","volume":"83","author":"Chan","year":"1986","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B58","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1002\/j.1460-2075.1991.tb07771.x","article-title":"The refined 2.15 A X-ray crystal structure of human liver cathepsin B: the structural basis for its specificity","volume":"10","author":"Musil","year":"1991","journal-title":"EMBO J"},{"key":"B59","doi-asserted-by":"publisher","first-page":"4516","DOI":"10.1073\/pnas.95.8.4516","article-title":"Cathepsins B and D are dispensable for major histocompatibility complex class II-mediated antigen presentation","volume":"95","author":"Deussing","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B60","first-page":"1079","article-title":"333. Cathepsin B","volume-title":"Handbook of Proteolytic Enzymes","author":"Mort","year":"2004","edition":"Second ed"},{"key":"B61","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1042\/bj1710759","article-title":"The specificity of cathepsin B. Hydrolysis of glucagon at the C-terminus by a peptidyldipeptidase mechanism","volume":"171","author":"Aronson","year":"1978","journal-title":"Biochem J"},{"key":"B62","doi-asserted-by":"crossref","first-page":"9375","DOI":"10.1016\/S0021-9258(18)67665-3","article-title":"Porcine spleen cathepsin B is an exopeptidase","volume":"261","author":"Takahashi","year":"1986","journal-title":"J Biol Chem"},{"key":"B63","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1074\/jbc.272.2.1197","article-title":"Role of the occluding loop in cathepsin B activity","volume":"272","author":"Illy","year":"1997","journal-title":"J Biol Chem"},{"key":"B64","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S0006-291X(67)80055-X","article-title":"On the size of the active site in proteases. I. Papain","volume":"27","author":"Schechter","year":"1967","journal-title":"Biochem Biophys Res Commun"},{"key":"B65","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1074\/mcp.M500004-MCP200","article-title":"High throughput substrate specificity profiling of serine and cysteine proteases using solution-phase fluorogenic peptide microarrays","volume":"4","author":"Gosalia","year":"2005","journal-title":"Mol Cell Proteomics"},{"key":"B66","doi-asserted-by":"publisher","first-page":"12824","DOI":"10.1074\/jbc.M513331200","article-title":"Substrate profiling of cysteine proteases using a combinatorial peptide library identifies functionally unique specificities","volume":"281","author":"Choe","year":"2006","journal-title":"J Biol Chem"},{"key":"B67","volume-title":"Handbook of Proteolytic Enzymes","author":"Barrett","year":"2004"},{"key":"B68","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1016\/0006-291X(68)90326-4","article-title":"On the active site of proteases. 3. Mapping the active site of papain; specific peptide inhibitors of papain","volume":"32","author":"Schechter","year":"1968","journal-title":"Biochem Biophys Res Commun"},{"key":"B69","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1515\/BC.2008.124","article-title":"Alternative pathways for production of beta-amyloid peptides of Alzheimer\u2019s disease","volume":"389","author":"Hook","year":"2008","journal-title":"Biol Chem"},{"key":"B70","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.bbapap.2011.10.002","article-title":"Cysteine cathepsins: from structure, function and regulation to new frontiers","volume":"1824","author":"Turk","year":"2012","journal-title":"Biochim Biophys Acta"},{"key":"B71","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1515\/BC.2004.040","article-title":"Comprehensive search for cysteine cathepsins in the human genome","volume":"385","author":"Rossi","year":"2004","journal-title":"Biol Chem"},{"key":"B72","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1007\/BF00207033","article-title":"Confirmation of the human cathepsin B gene (CTSB) assignment to chromosome 8","volume":"89","author":"Fong","year":"1992","journal-title":"Hum Genet"},{"key":"B73","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/0378-1119(95)00072-E","article-title":"Identification of two new exons and multiple transcription start points in the 5\u2019-untranslated region of the human cathepsin-B-encoding gene","volume":"159","author":"Berquin","year":"1995","journal-title":"Gene"},{"key":"B74","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1089\/dna.1993.12.299","article-title":"Characterization of the cathepsin B gene and multiple mRNAs in human tissues: evidence for alternative splicing of cathepsin B pre-mRNA","volume":"12","author":"Gong","year":"1993","journal-title":"DNA Cell Biol"},{"key":"B75","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/mp.2009.2","article-title":"Chromosome 8p as a potential hub for developmental neuropsychiatric disorders: implications for schizophrenia, autism and cancer","volume":"14","author":"Tabares-Seisdedos","year":"2009","journal-title":"Mol Psychiatry"},{"key":"B76","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1136\/gut.2005.087403","article-title":"Association of cathepsin B gene polymorphisms with tropical calcific pancreatitis","volume":"55","author":"Mahurkar","year":"2006","journal-title":"Gut"},{"key":"B77","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1089\/dna.1991.10.159","article-title":"The structure of the mouse cathepsin B gene and its putative promoter","volume":"10","author":"Qian","year":"1991","journal-title":"DNA Cell Biol"},{"key":"B78","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s003359900401","article-title":"The genes of the lysosomal cysteine proteinases cathepsin B, H, L, and S map to different mouse chromosomes","volume":"8","author":"Deussing","year":"1997","journal-title":"Mamm Genome"},{"key":"B79","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/BF00144018","article-title":"Overexpression and localization of cathepsin B during the progression of human gliomas","volume":"13","author":"Sivaparvathi","year":"1995","journal-title":"Clin Exp Metastasis"},{"key":"B80","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/j.cell.2009.01.035","article-title":"Origins and mechanisms of miRNAs and siRNAs","volume":"136","author":"Carthew","year":"2009","journal-title":"Cell"},{"key":"B81","doi-asserted-by":"publisher","first-page":"R13","DOI":"10.1186\/gb-2004-5-3-r13","article-title":"Expression profiling of mammalian microRNAs uncovers a subset of brain-expressed microRNAs with possible roles in murine and human neuronal differentiation","volume":"5","author":"Sempere","year":"2004","journal-title":"Genome Biol"},{"key":"B82","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1038\/nrneurol.2013.67","article-title":"The emerging roles of microRNAs in CNS injuries","volume":"9","author":"Bhalala","year":"2013","journal-title":"Nat Rev Neurol"},{"key":"B83","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1002\/jnr.21945","article-title":"Traumatic brain injury alters expression of hippocampal microRNAs: potential regulators of multiple pathophysiological processes","volume":"87","author":"Redell","year":"2009","journal-title":"J Neurosci Res"},{"key":"B84","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1074\/jbc.M112.396762","article-title":"MicroRNA 218 acts as a tumor suppressor by targeting multiple cancer phenotype-associated genes in medulloblastoma","volume":"288","author":"Venkataraman","year":"2013","journal-title":"J Biol Chem"},{"key":"B85","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.neurobiolaging.2013.08.003","article-title":"miR128 up-regulation correlates with impaired amyloid beta(1-42) degradation in monocytes from patients with sporadic Alzheimer\u2019s disease","volume":"35","author":"Tiribuzi","year":"2014","journal-title":"Neurobiol Aging"},{"key":"B86","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1096\/fj.06-6130com","article-title":"Post-transcriptional regulation of the let-7 microRNA during neural cell specification","volume":"21","author":"Wulczyn","year":"2007","journal-title":"FASEB J"},{"key":"B87","doi-asserted-by":"publisher","first-page":"375345","DOI":"10.1155\/2010\/375345","article-title":"Posttranslational processing and modification of cathepsins and cystatins","volume":"2010","author":"Katunuma","year":"2010","journal-title":"J Signal Transduct"},{"key":"B88","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/S0167-4838(99)00263-0","article-title":"Lysosomal cysteine proteases: more than scavengers","volume":"1477","author":"Turk","year":"2000","journal-title":"Biochim Biophys Acta"},{"key":"B89","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1126\/science.6369538","article-title":"Evolution of proteolytic enzymes","volume":"224","author":"Neurath","year":"1984","journal-title":"Science"},{"key":"B90","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1111\/j.1742-4658.2008.06815.x","article-title":"Autocatalytic processing of procathepsin B is triggered by proenzyme activity","volume":"276","author":"Pungercar","year":"2009","journal-title":"FEBS J"},{"key":"B91","doi-asserted-by":"crossref","first-page":"13030","DOI":"10.1016\/S0021-9258(18)99979-5","article-title":"Maturation of human procathepsin B. Proenzyme activation and proteolytic processing of the precursor to the mature proteinase, in vitro, are primarily unimolecular processes","volume":"269","author":"Mach","year":"1994","journal-title":"J Biol Chem"},{"key":"B92","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/S0006-291X(87)80028-1","article-title":"Autodegradation of lysosomal cysteine proteinases","volume":"144","author":"Kominami","year":"1987","journal-title":"Biochem Biophys Res Commun"},{"key":"B93","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1089\/089771503770195777","article-title":"Gene expression profile changes are commonly modulated across models and species after traumatic brain injury","volume":"20","author":"Natale","year":"2003","journal-title":"J Neurotrauma"},{"key":"B94","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.1002\/jnr.22453","article-title":"Cathepsin B contributes to traumatic brain injury-induced cell death through a mitochondria-mediated apoptotic pathway","volume":"88","author":"Luo","year":"2010","journal-title":"J Neurosci Res"},{"key":"B95","doi-asserted-by":"publisher","first-page":"e87241","DOI":"10.1371\/journal.pone.0087241","article-title":"Hydrogen sulfide offers neuroprotection on traumatic brain injury in parallel with reduced apoptosis and autophagy in mice","volume":"9","author":"Zhang","year":"2014","journal-title":"PLoS One"},{"issue":"404\u20136","key":"B96","first-page":"410","article-title":"Expression of cathepsin-B and -D in rat\u2019s brain after traumatic brain injury","volume":"22","author":"Zhang","year":"2006","journal-title":"Fa Yi Xue Za Zhi"},{"key":"B97","doi-asserted-by":"publisher","first-page":"5807","DOI":"10.3390\/ijms15045807","article-title":"Cystatin C has a dual role in post-traumatic brain injury recovery","volume":"15","author":"Martinez-Vargas","year":"2014","journal-title":"Int J Mol Sci"},{"key":"B98","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s10072-012-1007-z","article-title":"Therapeutic effect of SN50, an inhibitor of nuclear factor-kappaB, in treatment of TBI in mice","volume":"34","author":"Sun","year":"2013","journal-title":"Neurol Sci"},{"key":"B99","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1046\/j.1471-4159.2003.02197.x","article-title":"Cathepsin B mRNA and protein expression following contusion spinal cord injury in rats","volume":"88","author":"Ellis","year":"2004","journal-title":"J Neurochem"},{"key":"B100","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.expneurol.2004.11.034","article-title":"Cellular localization and enzymatic activity of cathepsin B after spinal cord injury in the rat","volume":"193","author":"Ellis","year":"2005","journal-title":"Exp Neurol"},{"key":"B101","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1515\/BC.2009.055","article-title":"Cathepsin B release from rodent intestine mucosa due to mechanical injury results in extracellular matrix damage in early post-traumatic phases","volume":"390","author":"Vreemann","year":"2009","journal-title":"Biol Chem"},{"key":"B102","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1111\/nan.12091","article-title":"Possible involvement of cathepsin B\/D and caspase-3 in deferoxamine-related neuroprotection of early brain injury after subarachnoid haemorrhage in rats","volume":"40","author":"Yu","year":"2014","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"1","key":"B103","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1007\/s12035-014-8846-y","article-title":"The neuroprotection of lysosomotropic agents in experimental subarachnoid hemorrhage probably involving the apoptosis pathway triggering by cathepsins via chelating intralysosomal iron","volume":"52","author":"Wang","year":"2014","journal-title":"Mol Neurobiol"},{"key":"B104","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1161\/STROKEAHA.107.513648","article-title":"Cathepsin B, K, and S are expressed in cerebral aneurysms and promote the progression of cerebral aneurysms","volume":"39","author":"Aoki","year":"2008","journal-title":"Stroke"},{"key":"B105","first-page":"83","article-title":"Causative role of lysosomal enzymes in the pathogenesis of cerebral lesions due to brain edema under chronic hypertension","volume":"60","author":"Yamada","year":"1994","journal-title":"Acta Neurochir Suppl (Wien)"},{"key":"B106","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1002\/jnr.20977","article-title":"Neurovascular and neuronal protection by E64d after focal cerebral ischemia in rats","volume":"84","author":"Tsubokawa","year":"2006","journal-title":"J Neurosci Res"},{"key":"B107","doi-asserted-by":"publisher","first-page":"716","DOI":"10.3171\/jns.1997.87.5.0716","article-title":"Cathepsin B and middle cerebral artery occlusion in the rat","volume":"87","author":"Seyfried","year":"1997","journal-title":"J Neurosurg"},{"key":"B108","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1046\/j.1460-9568.1998.00184.x","article-title":"Inhibition of ischaemic hippocampal neuronal death in primates with cathepsin B inhibitor CA-074: a novel strategy for neuroprotection based on \u2018calpain-cathepsin hypothesis\u2019","volume":"10","author":"Yamashima","year":"1998","journal-title":"Eur J Neurosci"},{"key":"B109","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1006\/exnr.1998.6988","article-title":"Postictal blockade of ischemic hippocampal neuronal death in primates using selective cathepsin inhibitors","volume":"155","author":"Tsuchiya","year":"1999","journal-title":"Exp Neurol"},{"key":"B110","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.bbrc.2007.11.104","article-title":"Effects of cathepsins B and L inhibition on postischemic protein alterations in the brain","volume":"366","author":"Anagli","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"key":"B111","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s11064-011-0578-z","article-title":"Long-term effects of recurrent neonatal seizures on neurobehavioral function and related gene expression and its intervention by inhibitor of cathepsin B","volume":"37","author":"Ni","year":"2012","journal-title":"Neurochem Res"},{"key":"B112","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.brainres.2005.10.074","article-title":"Lysosomal enzyme cathepsin B is involved in kainic acid-induced excitotoxicity in rat striatum","volume":"1071","author":"Wang","year":"2006","journal-title":"Brain Res"},{"key":"B113","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1172\/JCI111352","article-title":"Inhibitors of prostaglandin synthesis or cathepsin B prevent muscle wasting due to sepsis in the rat","volume":"73","author":"Ruff","year":"1984","journal-title":"J Clin Invest"},{"key":"B114","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1001\/archsurg.1988.01400260105013","article-title":"Evidence that cathepsin B contributes to skeletal muscle protein breakdown during sepsis","volume":"123","author":"Hummel","year":"1988","journal-title":"Arch Surg"},{"key":"B115","doi-asserted-by":"publisher","first-page":"11330","DOI":"10.1523\/JNEUROSCI.0677-12.2012","article-title":"Microglial cathepsin B contributes to the initiation of peripheral inflammation-induced chronic pain","volume":"32","author":"Sun","year":"2012","journal-title":"J Neurosci"},{"key":"B116","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1002\/glia.20906","article-title":"Involvement of cathepsin B in the processing and secretion of interleukin-1beta in chromogranin A-stimulated microglia","volume":"58","author":"Terada","year":"2010","journal-title":"Glia"},{"key":"B117","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s12031-007-9004-z","article-title":"Spinal cord mRNA profile in patients with ALS: comparison with transgenic mice expressing the human SOD-1 mutant","volume":"38","author":"Offen","year":"2009","journal-title":"J Mol Neurosci"},{"key":"B118","doi-asserted-by":"publisher","first-page":"9201","DOI":"10.1523\/JNEUROSCI.1470-07.2007","article-title":"Microarray analysis of the cellular pathways involved in the adaptation to and progression of motor neuron injury in the SOD1 G93A mouse model of familial ALS","volume":"27","author":"Ferraiuolo","year":"2007","journal-title":"J Neurosci"},{"key":"B119","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3389\/fnagi.2014.00075","article-title":"Deciphering the molecular profile of plaques, memory decline and neuron loss in two mouse models for Alzheimer\u2019s disease by deep sequencing","volume":"6","author":"Bouter","year":"2014","journal-title":"Front Aging Neurosci"},{"key":"B120","doi-asserted-by":"publisher","first-page":"269","DOI":"10.3233\/JAD-142805","article-title":"Translational study of Alzheimer\u2019s disease (AD) biomarkers from brain tissues in AbetaPP\/PS1 mice and serum of AD patients","volume":"45","author":"Sun","year":"2015","journal-title":"J Alzheimers Dis"},{"key":"B121","doi-asserted-by":"publisher","first-page":"177","DOI":"10.3109\/21678421.2012.729842","article-title":"Meta-analysis of gene expression profiling in amyotrophic lateral sclerosis: a comparison between transgenic mouse models and human patients","volume":"14","author":"Saris","year":"2013","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"B122","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.toxlet.2012.12.010","article-title":"Expression profiles of hippocampal regenerative sprouting-related genes and their regulation by E-64d in a developmental rat model of penicillin-induced recurrent epilepticus","volume":"217","author":"Ni","year":"2013","journal-title":"Toxicol Lett"},{"issue":"Suppl","key":"B123","first-page":"211","article-title":"Cathepsin B-indicator for the release of lysosomal cysteine proteinases in severe trauma and inflammation","volume":"371","author":"Assfalg-Machleidt","year":"1990","journal-title":"Biol Chem Hoppe Seyler"},{"key":"B124","first-page":"335","article-title":"Phagocyte proteinases in multiple trauma and sepsi: pathomechanims and related therapeutic approaches","volume-title":"Handbook of Mediators in Septic Shock","author":"Jochum","year":"1993"},{"key":"B125","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1212\/WNL.55.12.1828","article-title":"Cystatin C and cathepsin B in CSF from patients with inflammatory neurologic diseases","volume":"55","author":"Nagai","year":"2000","journal-title":"Neurology"},{"key":"B126","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/0022-510X(95)00039-5","article-title":"Increased cathepsin B activity in multiple sclerosis brain","volume":"131","author":"Bever","year":"1995","journal-title":"J Neurol Sci"},{"key":"B127","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1152\/physiolgenomics.00087.2001","article-title":"Molecular signature of late-stage human ALS revealed by expression profiling of postmortem spinal cord gray matter","volume":"16","author":"Dangond","year":"2004","journal-title":"Physiol Genomics"},{"key":"B128","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1007\/s00401-002-0667-9","article-title":"Involvement of cathepsin B in the motor neuron degeneration of amyotrophic lateral sclerosis","volume":"105","author":"Kikuchi","year":"2003","journal-title":"Acta Neuropathol"},{"key":"B129","doi-asserted-by":"publisher","first-page":"3861","DOI":"10.1073\/pnas.87.10.3861","article-title":"Enzymatically active lysosomal proteases are associated with amyloid deposits in Alzheimer brain","volume":"87","author":"Cataldo","year":"1990","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B130","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.3233\/JAD-2010-101023","article-title":"Higher cathepsin B levels in plasma in Alzheimer\u2019s disease compared to healthy controls","volume":"22","author":"Sundelof","year":"2010","journal-title":"J Alzheimers Dis"},{"key":"B131","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3233\/JAD-2005-7205","article-title":"Quantitative proteomics of cerebrospinal fluid from patients with Alzheimer disease","volume":"7","author":"Zhang","year":"2005","journal-title":"J Alzheimers Dis"},{"key":"B132","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1007\/s12017-013-8269-3","article-title":"Lysosomal network proteins as potential novel CSF biomarkers for Alzheimer\u2019s disease","volume":"16","author":"Armstrong","year":"2014","journal-title":"Neuromolecular Med"},{"key":"B133","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1002\/art.1780341116","article-title":"Cathepsin B in synovial cells at the site of joint destruction in rheumatoid arthritis","volume":"34","author":"Trabandt","year":"1991","journal-title":"Arthritis Rheum"},{"key":"B134","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1136\/ard.54.4.281","article-title":"Cathepsin B in osteoarthritis: cytochemical and histochemical analysis of human femoral head cartilage","volume":"54","author":"Baici","year":"1995","journal-title":"Ann Rheum Dis"},{"key":"B135","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1111\/j.1365-2249.2006.03188.x","article-title":"Cathepsins B, L and D in inflammatory bowel disease macrophages and potential therapeutic effects of cathepsin inhibition in vivo","volume":"146","author":"Menzel","year":"2006","journal-title":"Clin Exp Immunol"},{"key":"B136","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1515\/BC.2001.089","article-title":"Towards specific functions of lysosomal cysteine peptidases: phenotypes of mice deficient for cathepsin B or cathepsin L","volume":"382","author":"Reinheckel","year":"2001","journal-title":"Biol Chem"},{"key":"B137","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1172\/JCI15990","article-title":"Thyroid functions of mouse cathepsins B, K, and L","volume":"111","author":"Friedrichs","year":"2003","journal-title":"J Clin Invest"},{"key":"B138","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1002\/neu.10253","article-title":"Cathepsin B but not cathepsins L or S contributes to the pathogenesis of Unverricht-Lundborg progressive myoclonus epilepsy (EPM1)","volume":"56","author":"Houseweart","year":"2003","journal-title":"J Neurobiol"},{"key":"B139","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.bbrc.2009.05.131","article-title":"Genetic cathepsin B deficiency reduces beta-amyloid in transgenic mice expressing human wild-type amyloid precursor protein","volume":"386","author":"Hook","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"key":"B140","doi-asserted-by":"publisher","first-page":"827","DOI":"10.3233\/JAD-2012-111604","article-title":"Deletion of the cathepsin B gene improves memory deficits in a transgenic alzheimer\u2019s disease mouse model expressing AbetaPP containing the wild-type beta-secretase site sequence","volume":"29","author":"Kindy","year":"2012","journal-title":"J Alzheimers Dis"},{"key":"B141","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3233\/JAD-131370","article-title":"Brain pyroglutamate amyloid-beta is produced by cathepsin B and is reduced by the cysteine protease inhibitor E64d, representing a potential Alzheimer\u2019s disease therapeutic","volume":"41","author":"Hook","year":"2014","journal-title":"J Alzheimers Dis"},{"key":"B142","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.neuron.2006.07.027","article-title":"Antiamyloidogenic and neuroprotective functions of cathepsin B: implications for Alzheimer\u2019s disease","volume":"51","author":"Mueller-Steiner","year":"2006","journal-title":"Neuron"},{"key":"B143","doi-asserted-by":"publisher","first-page":"2715","DOI":"10.1016\/j.neurobiolaging.2013.05.018","article-title":"Differential pathways for interleukin-1beta production activated by chromogranin A and amyloid beta in microglia","volume":"34","author":"Wu","year":"2013","journal-title":"Neurobiol Aging"},{"key":"B144","doi-asserted-by":"publisher","first-page":"690","DOI":"10.4049\/jimmunol.181.1.690","article-title":"Cathepsin B is involved in the trafficking of TNF-alpha-containing vesicles to the plasma membrane in macrophages","volume":"181","author":"Ha","year":"2008","journal-title":"J Immunol"},{"key":"B145","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1053\/j.gastro.2005.05.022","article-title":"Bid is upstream of lysosome-mediated caspase 2 activation in tumor necrosis factor alpha-induced hepatocyte apoptosis","volume":"129","author":"Guicciardi","year":"2005","journal-title":"Gastroenterology"},{"key":"B146","doi-asserted-by":"publisher","first-page":"e0128945","DOI":"10.1371\/journal.pone.0128945","article-title":"Redundancy between cysteine cathepsins in murine experimental autoimmune encephalomyelitis","volume":"10","author":"Allan","year":"2015","journal-title":"PLoS One"},{"key":"B147","doi-asserted-by":"publisher","first-page":"38825","DOI":"10.1074\/jbc.R111.288308","article-title":"Pyroglutamate amyloid-beta (Abeta): a hatchet man in Alzheimer disease","volume":"286","author":"Jawhar","year":"2011","journal-title":"J Biol Chem"},{"key":"B148","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1515\/BC.2005.108","article-title":"Inhibition of cathepsin B reduces \u03b2-amyloid production in regulated secretory vesicles of neuronal chromaffin cells: evidence for cathepsin B as a candidate \u03b2-secretase of Alzheimer\u2019s disease","volume":"386","author":"Hook","year":"2005","journal-title":"Biol Chem"},{"key":"B149","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1515\/BC.2007.027","article-title":"Cysteine protease inhibitors effectively reduce in vivo levels of brain beta-amyloid related to Alzheimer\u2019s disease","volume":"388","author":"Hook","year":"2007","journal-title":"Biol Chem"},{"key":"B150","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1515\/BC.2007.027","article-title":"Cysteine protease inhibitors reduce brain beta-amyloid and beta-secretase activity in vivo and are potential Alzheimer\u2019s disease therapeutics","volume":"388","author":"Hook","year":"2007","journal-title":"Biol Chem"},{"key":"B151","doi-asserted-by":"publisher","first-page":"7745","DOI":"10.1074\/jbc.M708362200","article-title":"Inhibitors of cathepsin B improve memory and reduce Abeta in transgenic Alzheimer\u2019s Disease mice expressing the wild-type, but not the Swedish mutant, beta -secretase APP site","volume":"283","author":"Hook","year":"2008","journal-title":"J Biol Chem"},{"key":"B152","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1136\/jnnp.57.4.419","article-title":"Beta amyloid protein deposition in the brain after severe head injury: implications for the pathogenesis of Alzheimer\u2019s disease","volume":"57","author":"Roberts","year":"1994","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B153","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1111\/j.1750-3639.2008.00176.x","article-title":"A lack of amyloid beta plaques despite persistent accumulation of amyloid beta in axons of long-term survivors of traumatic brain injury","volume":"19","author":"Chen","year":"2009","journal-title":"Brain Pathol"},{"key":"B154","doi-asserted-by":"publisher","first-page":"30","DOI":"10.3389\/fneur.2013.00030","article-title":"Microglia activation as a biomarker for traumatic brain injury","volume":"4","author":"Hernandez-Ontiveros","year":"2013","journal-title":"Front Neurol"},{"key":"B155","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1097\/00004647-200208000-00008","article-title":"Elevated intracranial IL-18 in humans and mice after traumatic brain injury and evidence of neuroprotective effects of IL-18-binding protein after experimental closed head injury","volume":"22","author":"Yatsiv","year":"2002","journal-title":"J Cereb Blood Flow Metab"},{"key":"B156","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1097\/01.ta.0000196345.81169.a1","article-title":"The effect of traumatic brain injury upon the concentration and expression of interleukin-1beta and interleukin-10 in the rat","volume":"60","author":"Kamm","year":"2006","journal-title":"J Trauma"},{"key":"B157","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/jcbfm.2013.227","article-title":"Activation and regulation of cellular inflammasomes: gaps in our knowledge for central nervous system injury","volume":"34","author":"de Rivero Vaccari","year":"2014","journal-title":"J Cereb Blood Flow Metab"},{"key":"B158","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1038\/ni.1636","article-title":"The NALP3 inflammasome is involved in the innate immune response to amyloid-beta","volume":"9","author":"Halle","year":"2008","journal-title":"Nat Immunol"},{"key":"B159","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1172\/JCI11829","article-title":"A lysosomal protease enters the death scene","volume":"107","author":"Salvesen","year":"2001","journal-title":"J Clin Invest"},{"key":"B160","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/0165-5728(90)90105-V","article-title":"Elevation of tumor necrosis factor in head injury","volume":"30","author":"Goodman","year":"1990","journal-title":"J Neuroimmunol"},{"key":"B161","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1172\/JCI9914","article-title":"Cathepsin B contributes to TNF-alpha-mediated hepatocyte apoptosis by promoting mitochondrial release of cytochrome c","volume":"106","author":"Guicciardi","year":"2000","journal-title":"J Clin Invest"},{"key":"B162","doi-asserted-by":"publisher","first-page":"7883","DOI":"10.1073\/pnas.112632299","article-title":"Neuronal loss and brain atrophy in mice lacking cathepsins B and L","volume":"99","author":"Felbor","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B163","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1515\/BC.2006.112","article-title":"Human cathepsin L rescues the neurodegeneration and lethality in cathepsin B\/L double-deficient mice","volume":"387","author":"Sevenich","year":"2006","journal-title":"Biol Chem"},{"key":"B164","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1002\/path.1711450404","article-title":"The distribution of cathepsin B in human tissues","volume":"145","author":"Howie","year":"1985","journal-title":"J Pathol"},{"key":"B165","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/oxfordjournals.jbchem.a135277","article-title":"Distribution of cathepsins B and H in rat tissues and peripheral blood cells","volume":"98","author":"Kominami","year":"1985","journal-title":"J Biochem"},{"key":"B166","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/0014-5793(86)80618-4","article-title":"Differences in cathepsin B mRNA levels in rat tissues suggest specialized functions","volume":"201","author":"San Segundo","year":"1986","journal-title":"FEBS Lett"},{"key":"B167","doi-asserted-by":"publisher","first-page":"1260419","DOI":"10.1126\/science.1260419","article-title":"Proteomics. Tissue-based map of the human proteome","volume":"347","author":"Uhlen","year":"2015","journal-title":"Science"},{"key":"B168","first-page":"17","article-title":"Cathepsin B immunoreactivity is widely distributed in the rat brain","volume":"29","author":"Bernstein","year":"1988","journal-title":"J Hirnforsch"},{"key":"B169","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/0361-9230(90)90157-U","article-title":"Antigenic expression of cathepsin B in aged human brain","volume":"24","author":"Bernstein","year":"1990","journal-title":"Brain Res Bull"},{"key":"B170","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/0304-3940(91)90395-A","article-title":"Abnormal distribution of cathepsins in the brain of patients with Alzheimer\u2019s disease","volume":"130","author":"Nakamura","year":"1991","journal-title":"Neurosci Lett"},{"key":"B171","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/BF01614769","article-title":"Abnormal distribution of cathepsin proteinases and endogenous inhibitors (cystatins) in the hippocampus of patients with Alzheimer\u2019s disease, parkinsonism-dementia complex on Guam, and senile dementia and in the aged","volume":"423","author":"Ii","year":"1993","journal-title":"Virchows Arch A Pathol Anat Histopathol"},{"key":"B172","first-page":"313","article-title":"Cathepsin B immunoreactive neurons in rat brain. A combined light and electron microscopic study","volume":"30","author":"Bernstein","year":"1989","journal-title":"J Hirnforsch"},{"key":"B173","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/S0006-8993(99)01888-0","article-title":"Age-related changes in ultrastructural features of cathepsin B- and D-containing neurons in rat cerebral cortex","volume":"844","author":"Jung","year":"1999","journal-title":"Brain Res"},{"key":"B174","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/0306-4522(94)90190-2","article-title":"Differential distribution of messenger RNAs for cathepsins B, L and S in adult rat brain: an in situ hybridization study","volume":"59","author":"Petanceska","year":"1994","journal-title":"Neuroscience"},{"key":"B175","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1007\/s10072-012-1022-0","article-title":"Cerebrospinal fluid cathepsin B and S","volume":"34","author":"Nilsson","year":"2013","journal-title":"Neurol Sci"},{"key":"B176","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1006\/exnr.1994.1048","article-title":"Age-related changes in activities and localizations of cathepsins D, E, B, and L in the rat brain tissues","volume":"126","author":"Nakanishi","year":"1994","journal-title":"Exp Neurol"},{"key":"B177","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1111\/j.1432-1033.1983.tb07841.x","article-title":"Lysosomes revisited","volume":"137","author":"de Duve","year":"1983","journal-title":"Eur J Biochem"},{"key":"B178","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1016\/S0021-9258(18)69235-X","article-title":"Regulation of microautophagy and basal protein turnover in rat liver. Effects of short-term starvation","volume":"263","author":"Mortimore","year":"1988","journal-title":"J Biol Chem"},{"key":"B179","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/BF01923508","article-title":"Proteases and proteolysis in the lysosome","volume":"48","author":"Bohley","year":"1992","journal-title":"Experientia"},{"key":"B180","first-page":"1","article-title":"Lysosomes","volume":"12","author":"Dean","year":"1976","journal-title":"Essays Biochem"},{"key":"B181","doi-asserted-by":"crossref","first-page":"30238","DOI":"10.1016\/S0021-9258(18)43803-3","article-title":"Engineering the S2 subsite specificity of human cathepsin S to a cathepsin L- and cathepsin B-like specificity","volume":"269","author":"Bromme","year":"1994","journal-title":"J Biol Chem"},{"key":"B182","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1038\/nrm732","article-title":"Secretory lysosomes","volume":"3","author":"Blott","year":"2002","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B183","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1038\/ncb1620","article-title":"Regulated ATP release from astrocytes through lysosome exocytosis","volume":"9","author":"Zhang","year":"2007","journal-title":"Nat Cell Biol"},{"key":"B184","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1111\/boc.201100070","article-title":"TI-VAMP\/VAMP7 is the SNARE of secretory lysosomes contributing to ATP secretion from astrocytes","volume":"104","author":"Verderio","year":"2012","journal-title":"Biol Cell"},{"key":"B185","doi-asserted-by":"publisher","first-page":"23833","DOI":"10.1074\/jbc.272.38.23833","article-title":"Identification and characterization of cathepsin B as the cellular MARCKS cleaving enzyme","volume":"272","author":"Spizz","year":"1997","journal-title":"J Biol Chem"},{"key":"B186","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1016\/j.neuropharm.2004.08.004","article-title":"Cathepsin B-like proteolysis and MARCKS degradation in sub-lethal NMDA-induced collapse of dendritic spines","volume":"47","author":"Graber","year":"2004","journal-title":"Neuropharmacology"},{"key":"B187","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1515\/BC.2007.092","article-title":"Cleavage of the myristoylated alanine-rich C kinase substrate (MARCKS) by cysteine cathepsins in cells and tissues of stefin B-deficient mice","volume":"388","author":"Kopitar-Jerala","year":"2007","journal-title":"Biol Chem"},{"key":"B188","doi-asserted-by":"publisher","first-page":"4877","DOI":"10.1242\/jcs.00184","article-title":"Trafficking of lysosomal cathepsin B-green fluorescent protein to the surface of thyroid epithelial cells involves the endosomal\/lysosomal compartment","volume":"115","author":"Linke","year":"2002","journal-title":"J Cell Sci"},{"key":"B189","doi-asserted-by":"publisher","first-page":"240","DOI":"10.4161\/auto.7.2.14286","article-title":"14-3-3zeta binds class III phosphatidylinositol-3-kinase and inhibits autophagy","volume":"7","author":"Pozuelo-Rubio","year":"2011","journal-title":"Autophagy"},{"key":"B190","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1007\/s00709-014-0730-0","article-title":"Proteolysis mediated by cysteine cathepsins and legumain-recent advances and cell biological challenges","volume":"252","author":"Brix","year":"2015","journal-title":"Protoplasma"},{"key":"B191","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1126\/science.2994224","article-title":"Pathways of protein secretion in eukaryotes","volume":"230","author":"Kelly","year":"1985","journal-title":"Science"},{"key":"B192","doi-asserted-by":"publisher","first-page":"21389","DOI":"10.1074\/jbc.M200878200","article-title":"Presence of cathepsin B in the human pancreatic secretory pathway and its role in trypsinogen activation during hereditary pancreatitis","volume":"277","author":"Kukor","year":"2002","journal-title":"J Biol Chem"},{"key":"B193","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1172\/JCI9411","article-title":"Role of cathepsin B in intracellular trypsinogen activation and the onset of acute pancreatitis","volume":"106","author":"Halangk","year":"2000","journal-title":"J Clin Invest"},{"key":"B194","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1083\/jcb.137.3.595","article-title":"Differential sorting of lysosomal enzymes out of the regulated secretory pathway in pancreatic beta-cells","volume":"137","author":"Kuliawat","year":"1997","journal-title":"J Cell Biol"},{"key":"B195","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1291\/hypres.18.131","article-title":"Role of cathepsin B as prorenin processing enzyme in human kidney","volume":"18","author":"Shinagawa","year":"1995","journal-title":"Hypertens Res"},{"key":"B196","doi-asserted-by":"publisher","first-page":"14800","DOI":"10.1021\/bi00253a019","article-title":"Human cathepsin B is a metastable enzyme stabilized by specific ionic interactions associated with the active site","volume":"33","author":"Turk","year":"1994","journal-title":"Biochemistry"},{"key":"B197","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1016\/j.chembiol.2009.07.011","article-title":"Direct measurement of cathepsin B activity in the cytosol of apoptotic cells by an activity-based probe","volume":"16","author":"Pratt","year":"2009","journal-title":"Chem Biol"},{"key":"B198","doi-asserted-by":"crossref","first-page":"14448","DOI":"10.1016\/S0021-9258(18)47815-5","article-title":"Dissociation of ionizing groups in the binding cleft inversely controls the endo- and exopeptidase activities of cathepsin B","volume":"262","author":"Polgar","year":"1987","journal-title":"J Biol Chem"},{"key":"B199","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1074\/jbc.M003820200","article-title":"Cathepsin B activity regulation. Heparin-like glycosaminogylcans protect human cathepsin B from alkaline pH-induced inactivation","volume":"276","author":"Almeida","year":"2001","journal-title":"J Biol Chem"},{"key":"B200","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1021\/bi00052a046","article-title":"Kinetics of the pH-induced inactivation of human cathepsin L","volume":"32","author":"Turk","year":"1993","journal-title":"Biochemistry"},{"key":"B201","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.2174\/1381612023394124","article-title":"Regulating cysteine protease activity: essential role of protease inhibitors as guardians and regulators","volume":"8","author":"Turk","year":"2002","journal-title":"Curr Pharm Des"},{"key":"B202","doi-asserted-by":"crossref","first-page":"11282","DOI":"10.1016\/S0021-9258(18)67380-6","article-title":"Isolation of six cysteine proteinase inhibitors from human urine. Their physicochemical and enzyme kinetic properties and concentrations in biological fluids","volume":"261","author":"Abrahamson","year":"1986","journal-title":"J Biol Chem"},{"key":"B203","doi-asserted-by":"publisher","first-page":"471","DOI":"10.3233\/JAD-2010-091594","article-title":"Cystatin C levels are positively correlated with both Abeta42 and tau levels in cerebrospinal fluid in persons with Alzheimer\u2019s disease, mild cognitive impairment, and healthy controls","volume":"21","author":"Sundelof","year":"2010","journal-title":"J Alzheimers Dis"},{"key":"B204","volume-title":"Ciba Foundation Symposium: Lysosomes; [Proceedings]","author":"de Duve","year":"1963"},{"key":"B205","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1038\/jcbfm.2012.95","article-title":"Increased intracranial pressure after diffuse traumatic brain injury exacerbates neuronal somatic membrane poration but not axonal injury: evidence for primary intracranial pressure-induced neuronal perturbation","volume":"32","author":"Lafrenaye","year":"2012","journal-title":"J Cereb Blood Flow Metab"},{"key":"B206","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1089\/neu.2012.2425","article-title":"Poloxamer 188 attenuates in vitro traumatic brain injury-induced mitochondrial and lysosomal membrane permeabilization damage in cultured primary neurons","volume":"30","author":"Luo","year":"2013","journal-title":"J Neurotrauma"},{"key":"B207","doi-asserted-by":"publisher","first-page":"2856","DOI":"10.1007\/s11064-012-0880-4","article-title":"Poloxamer-188 attenuates TBI-induced blood-brain barrier damage leading to decreased brain edema and reduced cellular death","volume":"37","author":"Bao","year":"2012","journal-title":"Neurochem Res"},{"key":"B208","doi-asserted-by":"publisher","first-page":"e61641","DOI":"10.1371\/journal.pone.0061641","article-title":"Poloxamer 188 protects neurons against ischemia\/reperfusion injury through preserving integrity of cell membranes and blood brain barrier","volume":"8","author":"Gu","year":"2013","journal-title":"PLoS One"},{"key":"B209","doi-asserted-by":"publisher","first-page":"2540","DOI":"10.2353\/ajpath.2009.081096","article-title":"Increased activity and altered subcellular distribution of lysosomal enzymes determine neuronal vulnerability in Niemann-Pick type C1-deficient mice","volume":"175","author":"Amritraj","year":"2009","journal-title":"Am J Pathol"},{"key":"B210","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1002\/jnr.22338","article-title":"Nuclear translocation of mitochondrial cytochrome c, lysosomal cathepsins B and D, and three other death-promoting proteins within the first 60 minutes of generalized seizures","volume":"88","author":"Zhao","year":"2010","journal-title":"J Neurosci Res"},{"key":"B211","doi-asserted-by":"publisher","first-page":"e55375","DOI":"10.1371\/journal.pone.0055375","article-title":"Triggering of inflammasome by aggregated alpha-synuclein, an inflammatory response in synucleinopathies","volume":"8","author":"Codolo","year":"2013","journal-title":"PLoS One"},{"key":"B212","doi-asserted-by":"publisher","first-page":"e62143","DOI":"10.1371\/journal.pone.0062143","article-title":"Alpha-synuclein induces lysosomal rupture and cathepsin dependent reactive oxygen species following endocytosis","volume":"8","author":"Freeman","year":"2013","journal-title":"PLoS One"},{"key":"B213","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1006\/nbdi.2000.0364","article-title":"Lysosomal membrane damage in soluble Abeta-mediated cell death in Alzheimer\u2019s disease","volume":"8","author":"Ditaranto","year":"2001","journal-title":"Neurobiol Dis"},{"key":"B214","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1242\/jcs.091181","article-title":"Lysosomal cell death at a glance","volume":"126","author":"Aits","year":"2013","journal-title":"J Cell Sci"},{"key":"B215","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.pneurobio.2009.09.003","article-title":"The role of lysosomal rupture in neuronal death","volume":"89","author":"Yamashima","year":"2009","journal-title":"Prog Neurobiol"},{"key":"B216","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pneurobio.2013.02.004","article-title":"Reconsider Alzheimer\u2019s disease by the \u2018calpain-cathepsin hypothesis\u2019 \u2013 a perspective review","volume":"105","author":"Yamashima","year":"2013","journal-title":"Prog Neurobiol"},{"key":"B217","doi-asserted-by":"publisher","first-page":"27432","DOI":"10.1074\/jbc.M114.560334","article-title":"Heat shock protein 70.1 (Hsp70.1) affects neuronal cell fate by regulating lysosomal acid sphingomyelinase","volume":"289","author":"Zhu","year":"2014","journal-title":"J Biol Chem"},{"key":"B218","doi-asserted-by":"publisher","first-page":"G947","DOI":"10.1152\/ajpgi.00151.2002","article-title":"Tumor necrosis factor-alpha-associated lysosomal permeabilization is cathepsin B dependent","volume":"283","author":"Werneburg","year":"2002","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"B219","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.freeradbiomed.2006.03.007","article-title":"Oxidative stress in head trauma in aging","volume":"41","author":"Shao","year":"2006","journal-title":"Free Radic Biol Med"},{"key":"B220","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/sj.jcbfm.9600068","article-title":"Enhanced oxidative stress in iNOS-deficient mice after traumatic brain injury: support for a neuroprotective role of iNOS","volume":"25","author":"Bayir","year":"2005","journal-title":"J Cereb Blood Flow Metab"},{"key":"B221","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s00418-008-0394-y","article-title":"Lysosomes in iron metabolism, ageing and apoptosis","volume":"129","author":"Kurz","year":"2008","journal-title":"Histochem Cell Biol"},{"key":"B222","doi-asserted-by":"publisher","first-page":"6434","DOI":"10.1038\/onc.2008.310","article-title":"Lysosomal membrane permeabilization in cell death","volume":"27","author":"Boya","year":"2008","journal-title":"Oncogene"},{"key":"B223","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1046\/j.1440-1789.1999.00259.x","article-title":"Ischemic delayed neuronal death: role of the cysteine proteases calpain and cathepsins","volume":"19","author":"Tontchev","year":"1999","journal-title":"Neuropathology"},{"key":"B224","doi-asserted-by":"publisher","first-page":"2881","DOI":"10.1038\/sj.onc.1207512","article-title":"Lysosomes in cell death","volume":"23","author":"Guicciardi","year":"2004","journal-title":"Oncogene"},{"key":"B225","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.4161\/cc.24903","article-title":"Role of lysosome rupture in controlling Nlrp3 signaling and necrotic cell death","volume":"12","author":"Lima","year":"2013","journal-title":"Cell Cycle"},{"key":"B226","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1101\/gad.14.16.2060","article-title":"tBID, a membrane-targeted death ligand, oligomerizes BAK to release cytochrome c","volume":"14","author":"Wei","year":"2000","journal-title":"Genes Dev"},{"key":"B227","doi-asserted-by":"publisher","first-page":"3719","DOI":"10.1182\/blood-2003-04-1075","article-title":"Cathepsin-B-dependent apoptosis triggered by antithymocyte globulins: a novel mechanism of T-cell depletion","volume":"102","author":"Michallet","year":"2003","journal-title":"Blood"},{"key":"B228","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1046\/j.1471-4159.2001.00146.x","article-title":"Microglial secreted cathepsin B induces neuronal apoptosis","volume":"76","author":"Kingham","year":"2001","journal-title":"J Neurochem"},{"key":"B229","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1038\/ni.1631","article-title":"Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization","volume":"9","author":"Hornung","year":"2008","journal-title":"Nat Immunol"},{"key":"B230","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1006\/bbrc.1998.9425","article-title":"Cathepsin B-mediated activation of the proinflammatory caspase-11","volume":"251","author":"Schotte","year":"1998","journal-title":"Biochem Biophys Res Commun"},{"key":"B231","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1083\/jcb.149.3.613","article-title":"Dual role of caspase-11 in mediating activation of caspase-1 and caspase-3 under pathological conditions","volume":"149","author":"Kang","year":"2000","journal-title":"J Cell Biol"},{"key":"B232","doi-asserted-by":"publisher","first-page":"538141","DOI":"10.1155\/2008\/538141","article-title":"Peroxisome proliferator-activated receptors: \u201ckey\u201d regulators of neuroinflammation after traumatic brain injury","volume":"2008","author":"Stahel","year":"2008","journal-title":"PPAR Res"},{"key":"B233","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.neulet.2005.06.019","article-title":"Fenofibrate, a peroxisome proliferator-activated receptor alpha agonist, exerts neuroprotective effects in traumatic brain injury","volume":"388","author":"Besson","year":"2005","journal-title":"Neurosci Lett"},{"key":"B234","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1089\/neu.2006.0216","article-title":"Neurological recovery-promoting, anti-inflammatory, and anti-oxidative effects afforded by fenofibrate, a PPAR alpha agonist, in traumatic brain injury","volume":"24","author":"Chen","year":"2007","journal-title":"J Neurotrauma"},{"key":"B235","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1111\/exd.12002","article-title":"Ligand activation of peroxisome proliferator-activated receptor delta suppresses cathepsin B expression in human endothelial cells in a posttranslational manner","volume":"21","author":"Reichenbach","year":"2012","journal-title":"Exp Dermatol"},{"key":"B236","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1093\/brain\/awg061","article-title":"Axonal damage: a key predictor of outcome in human CNS diseases","volume":"126","author":"Medana","year":"2003","journal-title":"Brain"},{"key":"B237","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.neuron.2005.08.027","article-title":"Essential role for the PKC target MARCKS in maintaining dendritic spine morphology","volume":"48","author":"Calabrese","year":"2005","journal-title":"Neuron"},{"key":"B238","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1038\/sj.jcbfm.9600551","article-title":"Autophagy is increased after traumatic brain injury in mice and is partially inhibited by the antioxidant gamma-glutamylcysteinyl ethyl ester","volume":"28","author":"Lai","year":"2008","journal-title":"J Cereb Blood Flow Metab"},{"key":"B239","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s12264-008-1108-0","article-title":"Autophagy is activated and might protect neurons from degeneration after traumatic brain injury","volume":"24","author":"Zhang","year":"2008","journal-title":"Neurosci Bull"},{"key":"B240","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1007\/s11064-012-0791-4","article-title":"Necrostatin-1 suppresses autophagy and apoptosis in mice traumatic brain injury model","volume":"37","author":"Wang","year":"2012","journal-title":"Neurochem Res"},{"key":"B241","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.neuroscience.2011.03.021","article-title":"Autophagy is involved in traumatic brain injury-induced cell death and contributes to functional outcome deficits in mice","volume":"184","author":"Luo","year":"2011","journal-title":"Neuroscience"},{"key":"B242","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/S0076-6879(08)03613-6","article-title":"Cytosolic LC3 ratio as a quantitative index of macroautophagy","volume":"452","author":"Kadowaki","year":"2009","journal-title":"Methods Enzymol"},{"key":"B243","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1038\/cdd.2010.191","article-title":"The beclin 1 network regulates autophagy and apoptosis","volume":"18","author":"Kang","year":"2011","journal-title":"Cell Death Differ"},{"key":"B244","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/S0076-6879(08)03612-4","article-title":"Monitoring autophagic degradation of p62\/SQSTM1","volume":"452","author":"Bjorkoy","year":"2009","journal-title":"Methods Enzymol"},{"key":"B245","doi-asserted-by":"publisher","first-page":"10850","DOI":"10.1074\/jbc.M109.080796","article-title":"Dual role of 3-methyladenine in modulation of autophagy via different temporal patterns of inhibition on class I and III phosphoinositide 3-kinase","volume":"285","author":"Wu","year":"2010","journal-title":"J Biol Chem"},{"key":"B246","doi-asserted-by":"publisher","first-page":"151","DOI":"10.4161\/auto.5338","article-title":"Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes","volume":"4","author":"Klionsky","year":"2008","journal-title":"Autophagy"},{"key":"B247","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1097\/01.WCB.0000138664.17682.32","article-title":"Caspase inhibitor z-DEVD-fmk attenuates calpain and necrotic cell death in vitro and after traumatic brain injury","volume":"24","author":"Knoblach","year":"2004","journal-title":"J Cereb Blood Flow Metab"},{"key":"B248","doi-asserted-by":"publisher","first-page":"187873","DOI":"10.1155\/2013\/187873","article-title":"Inhibition of cathepsin S produces neuroprotective effects after traumatic brain injury in mice","volume":"2013","author":"Xu","year":"2013","journal-title":"Mediators Inflamm"},{"key":"B249","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/S0006-8993(00)02260-5","article-title":"E-64-d prevents both calpain upregulation and apoptosis in the lesion and penumbra following spinal cord injury in rats","volume":"867","author":"Ray","year":"2000","journal-title":"Brain Res"},{"key":"B250","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0006-8993(90)90269-H","article-title":"Suppressive effect of E-64c on ischemic degradation of cerebral proteins following occlusion of the middle cerebral artery in rats","volume":"526","author":"Inuzuka","year":"1990","journal-title":"Brain Res"},{"key":"B251","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/S0006-8993(01)02289-2","article-title":"A selective cysteine protease inhibitor is non-toxic and cerebroprotective in rats undergoing transient middle cerebral artery ischemia","volume":"901","author":"Seyfried","year":"2001","journal-title":"Brain Res"},{"key":"B252","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s00401-002-0554-4","article-title":"Primate neurons show different vulnerability to transient ischemia and response to cathepsin inhibition","volume":"104","author":"Yoshida","year":"2002","journal-title":"Acta Neuropathol"},{"key":"B253","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.3171\/2010.6.JNS091856","article-title":"Improvement in recovery after experimental intracerebral hemorrhage using a selective cathepsin B and L inhibitor","volume":"114","author":"Yang","year":"2011","journal-title":"J Neurosurg"},{"key":"B254","doi-asserted-by":"publisher","first-page":"G894","DOI":"10.1152\/ajpgi.00073.2012","article-title":"Active cathepsins B, L, and S in murine and human pancreatitis","volume":"303","author":"Lyo","year":"2012","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"B255","doi-asserted-by":"publisher","first-page":"2796","DOI":"10.1172\/JCI34254","article-title":"Inhibition of calpains improves memory and synaptic transmission in a mouse model of Alzheimer disease","volume":"118","author":"Trinchese","year":"2008","journal-title":"J Clin Invest"},{"key":"B256","doi-asserted-by":"publisher","first-page":"387","DOI":"10.3233\/JAD-2011-110101","article-title":"The cysteine protease inhibitor, E64d, reduces brain amyloid-beta and improves memory deficits in Alzheimer\u2019s disease animal models by inhibiting cathepsin B, but not BACE1, beta-secretase activity","volume":"26","author":"Hook","year":"2011","journal-title":"J Alzheimers Dis"},{"key":"B257","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1271\/bbb1961.42.523","article-title":"Isolation and characterization of E-64, a new thiol protease inhibitor","volume":"42","author":"Hanada","year":"1978","journal-title":"Agric Biol Chem"},{"key":"B258","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1042\/bj2300509","article-title":"Calpain inhibition by peptide epoxides","volume":"230","author":"Parkes","year":"1985","journal-title":"Biochem J"},{"key":"B259","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1093\/oxfordjournals.jbchem.a135457","article-title":"Inactivation of calpain I and calpain II by specificity-oriented tripeptidyl chloromethyl ketones","volume":"99","author":"Sasaki","year":"1986","journal-title":"J Biochem"},{"key":"B260","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1479-5876-2-6","article-title":"Human primary osteoclasts: in vitro generation and applications as pharmacological and clinical assay","volume":"2","author":"Susa","year":"2004","journal-title":"J Transl Med"},{"key":"B261","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1093\/oxfordjournals.jbchem.a133155","article-title":"Inhibitions by E-64 derivatives of rat liver cathepsin B and cathepsin L in vitro and in vivo","volume":"88","author":"Hashida","year":"1980","journal-title":"J Biochem"},{"key":"B262","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1248\/bpb1978.9.672","article-title":"In vitro and in vivo inhibition of cysteine proteinases by EST, a new analog of E-64","volume":"9","author":"Tamai","year":"1986","journal-title":"J Pharmacobiodyn"},{"key":"B263","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1093\/oxfordjournals.jbchem.a133458","article-title":"Papain inhibitions by optically active E-64 analogs","volume":"90","author":"Tamai","year":"1981","journal-title":"J Biochem"},{"key":"B264","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/0014-5793(91)80318-W","article-title":"Novel epoxysuccinyl peptides. Selective inhibitors of cathepsin B, in vitro","volume":"280","author":"Murata","year":"1991","journal-title":"FEBS Lett"},{"key":"B265","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/0014-5793(91)80319-X","article-title":"Novel epoxysuccinyl peptides. A selective inhibitor of cathepsin B, in vivo","volume":"280","author":"Towatari","year":"1991","journal-title":"FEBS Lett"},{"key":"B266","doi-asserted-by":"publisher","first-page":"29","DOI":"10.2183\/pjab.87.29","article-title":"Structure-based development of specific inhibitors for individual cathepsins and their medical applications","volume":"87","author":"Katunuma","year":"2011","journal-title":"Proc Jpn Acad Ser B Phys Biol Sci"},{"key":"B267","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1515\/BC.2002.147","article-title":"CA-074, but not its methyl ester CA-074Me, is a selective inhibitor of cathepsin B within living cells","volume":"383","author":"Montaser","year":"2002","journal-title":"Biol Chem"},{"key":"B268","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S1074-5521(00)00061-2","article-title":"Selective targeting of lysosomal cysteine proteases with radiolabeled electrophilic substrate analogs","volume":"7","author":"Bogyo","year":"2000","journal-title":"Chem Biol"},{"key":"B269","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/0003-9861(92)90290-D","article-title":"CA074 methyl ester: a proinhibitor for intracellular cathepsin B","volume":"299","author":"Buttle","year":"1992","journal-title":"Arch Biochem Biophys"},{"key":"B270","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1038\/sj.cdd.4401247","article-title":"Inhibition of papain-like cysteine proteases and legumain by caspase-specific inhibitors: when reaction mechanism is more important than specificity","volume":"10","author":"Rozman-Pungercar","year":"2003","journal-title":"Cell Death Differ"},{"key":"B271","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/S0014-5793(98)01640-8","article-title":"Non-specific effects of methyl ketone peptide inhibitors of caspases","volume":"442","author":"Schotte","year":"1999","journal-title":"FEBS Lett"},{"key":"B272","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/S0014-5793(98)01275-7","article-title":"Atractyloside-induced release of cathepsin B, a protease with caspase-processing activity","volume":"438","author":"Vancompernolle","year":"1998","journal-title":"FEBS Lett"},{"key":"B273","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/S0090-9556(24)15083-0","article-title":"In vitro evaluation of the disposition of a novel cysteine protease inhibitor","volume":"28","author":"Jacobsen","year":"2000","journal-title":"Drug Metab Dispos"},{"key":"B274","doi-asserted-by":"publisher","DOI":"10.1089\/neu.2014.3672","article-title":"Serum GFAP predicts tissue GFAP break down products and therapeutic efficacy after penetrating ballistic-like brain injury","author":"Boutte","year":"2015","journal-title":"J Neurotrauma"},{"key":"B275","doi-asserted-by":"publisher","first-page":"S15","DOI":"10.1097\/TA.0b013e31822117fe","article-title":"A novel multicenter preclinical drug screening and biomarker consortium for experimental traumatic brain injury: operation brain trauma therapy","volume":"71","author":"Kochanek","year":"2011","journal-title":"J Trauma"},{"key":"B276","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.expneurol.2007.01.023","article-title":"Temporal relationship of peroxynitrite-induced oxidative damage, calpain-mediated cytoskeletal degradation and neurodegeneration after traumatic brain injury","volume":"205","author":"Deng","year":"2007","journal-title":"Exp Neurol"},{"key":"B277","doi-asserted-by":"publisher","first-page":"13182","DOI":"10.1074\/jbc.M111.302612","article-title":"Targeted gene inactivation of calpain-1 suppresses cortical degeneration due to traumatic brain injury and neuronal apoptosis induced by oxidative stress","volume":"287","author":"Yamada","year":"2012","journal-title":"J Biol Chem"},{"key":"B278","doi-asserted-by":"crossref","first-page":"7037","DOI":"10.1523\/JNEUROSCI.20-18-07037.2000","article-title":"Effects of matrix metalloproteinase-9 gene knock-out on morphological and motor outcomes after traumatic brain injury","volume":"20","author":"Wang","year":"2000","journal-title":"J Neurosci"},{"key":"B279","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.1038\/sj.onc.1207338","article-title":"Blockade of cathepsin B expression in human glioblastoma cells is associated with suppression of angiogenesis","volume":"23","author":"Yanamandra","year":"2004","journal-title":"Oncogene"},{"key":"B280","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1161\/01.STR.0000227259.15506.24","article-title":"Cathepsin and calpain inhibitor E64d attenuates matrix metalloproteinase-9 activity after focal cerebral ischemia in rats","volume":"37","author":"Tsubokawa","year":"2006","journal-title":"Stroke"},{"key":"B281","doi-asserted-by":"publisher","first-page":"6054","DOI":"10.1021\/jm4006719","article-title":"Design, synthesis, and optimization of novel epoxide incorporating peptidomimetics as selective calpain inhibitors","volume":"56","author":"Schiefer","year":"2013","journal-title":"J Med Chem"},{"key":"B282","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1248\/bpb1978.10.678","article-title":"Prolongation of life span of dystrophic hamster by cysteine proteinase inhibitor, loxistation (EST)","volume":"10","author":"Tamai","year":"1987","journal-title":"J Pharmacobiodyn"},{"key":"B283","doi-asserted-by":"publisher","first-page":"841","DOI":"10.2169\/internalmedicine.31.841","article-title":"Therapeutic trials on progressive muscular dystrophy","volume":"31","author":"Satoyoshi","year":"1992","journal-title":"Intern Med"},{"key":"B284","first-page":"362","article-title":"Pharmacokinetics of EST (report 5): pharmacokinetics of EST ih humans","volume":"20","author":"Watanabe","year":"1986","journal-title":"Kiso Rinsho"},{"key":"B285","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1042\/bj2010189","article-title":"L-trans-Epoxysuccinyl-leucylamido(4-guanidino)butane (E-64) and its analogues as inhibitors of cysteine proteinases including cathepsins B, H and L","volume":"201","author":"Barrett","year":"1982","journal-title":"Biochem J"},{"key":"B286","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1093\/oxfordjournals.jbchem.a134264","article-title":"Reaction of calcium-activated neutral protease (CANP) with an epoxysuccinyl derivative (E64c) and iodoacetic acid","volume":"93","author":"Suzuki","year":"1983","journal-title":"J Biochem"},{"key":"B287","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1146\/annurev.biochem.75.101304.124125","article-title":"Activity-based protein profiling: from enzyme chemistry to proteomic chemistry","volume":"77","author":"Cravatt","year":"2008","journal-title":"Annu Rev Biochem"},{"key":"B288","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1146\/annurev-biochem-060713-035708","article-title":"Enzyme inhibitor discovery by activity-based protein profiling","volume":"83","author":"Niphakis","year":"2014","journal-title":"Annu Rev Biochem"},{"key":"B289","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1146\/annurev-biochem-060713-035352","article-title":"Activity-based profiling of proteases","volume":"83","author":"Sanman","year":"2014","journal-title":"Annu Rev Biochem"},{"key":"B290","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1038\/nchembio.2007.26","article-title":"Noninvasive optical imaging of cysteine protease activity using fluorescently quenched activity-based probes","volume":"3","author":"Blum","year":"2007","journal-title":"Nat Chem Biol"},{"key":"B291","doi-asserted-by":"publisher","first-page":"2626","DOI":"10.1096\/fj.10-180604","article-title":"Identification of a myeloid-derived suppressor cell cystatin-like protein that inhibits metastasis","volume":"25","author":"Boutte","year":"2011","journal-title":"FASEB J"},{"key":"B292","first-page":"319","article-title":"Pharmacokinetics of EST (report 1): absorption and excretion of 14C-EST","volume":"20","author":"Fukushima","year":"1986","journal-title":"Kiso Rinsho"},{"key":"B293","first-page":"328","article-title":"Pharmacokinetics of EST (report 2): tissue distribution of 14C-EST","volume":"20","author":"Fukushima","year":"1986","journal-title":"Kiso Rinsho"},{"key":"B294","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1093\/oxfordjournals.jbchem.a133626","article-title":"The effect of an in vivo-injected thiol protease inhibitor, E-64-c, on the calcium-induced degeneration of myofilaments","volume":"90","author":"Ishiura","year":"1981","journal-title":"J Biochem"},{"key":"B295","doi-asserted-by":"publisher","first-page":"537","DOI":"10.3999\/jscpt.16.357","article-title":"Clinical phase I trial of thiol protease inhibitor (Report 2): safety and pharmacokinetics in continuous administration","volume":"16","author":"Miyahara","year":"1985","journal-title":"Rinsho Yakuri"},{"key":"B296","doi-asserted-by":"publisher","first-page":"357","DOI":"10.3999\/jscpt.16.357","article-title":"Phase I clinical trial of thiol protease inhibitor EST (report 1): safety and pharmacokinetics with single administration","volume":"16","author":"Miyahara","year":"1985","journal-title":"Rinsho Yakuri"},{"key":"B297","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.3109\/00498259009046825","article-title":"Metabolic fate of loxistatin in rat","volume":"20","author":"Fukushima","year":"1990","journal-title":"Xenobiotica"},{"key":"B298","first-page":"815","article-title":"Toxicological studies on ethyl(+)-(2S,2S)-3[(S)-3-methyl-1-(3-methylbutylcarbamoyl)butylcarbamoyl]-2-oxiranecarboxylate (EST)(report IX) mutagenicity study","volume":"17","author":"Yasui","year":"1986","journal-title":"Iyakuhin Kenkyu"},{"key":"B299","first-page":"736","article-title":"Toxicological studies of ethyl (+)-(2S,3S)-3-[(S)-3-methyl-1-(3-methylbutylcarbamoyl)butylcarbamoyl]-2-oxiranecarboxylate (EST) (report 1): acute toxicity studies of EST and metabolite and by-product of EST","volume":"17","author":"Setoyama","year":"1986","journal-title":"Iyakuhin Kenkyu"},{"key":"B300","first-page":"768","article-title":"Toxicological studies on ethyl(+)-(2S,2S)-3[(S)-3-methyl-1-(3-methylbutylcarbamoyl)butylcarbamoyl]-2-oxiranecarboxylate (EST)(report V) subacute toxicity in dogs","volume":"17","author":"Tarumoto","year":"1986","journal-title":"Iyakuhin Kenkyu"},{"key":"B301","first-page":"744","article-title":"Toxicological studies on ethyl(+)-(2S,2S)-3[(S)-3-methyl-1-(3-methylbutylcarbamoyl)butylcarbamoyl]-2-oxiranecarboxylate (EST) (report III) subacute toxicity in rats","volume":"17","author":"Kimura","year":"1986","journal-title":"Iyakuhin Kenkyu"},{"key":"B302","first-page":"802","article-title":"Toxicological studies on ethyl(+)-(2S,2S)-3[(S)-3-methyl-1-(3-methylbutylcarbamoyl)butylcarbamoyl]-2-oxiranecarboxylate (EST)(report VII) chronic toxicity study in dogs","volume":"17","author":"Tarumoto","year":"1986","journal-title":"Iyakuhin Kenkyu"},{"key":"B303","first-page":"781","article-title":"Toxicological studies on ethyl(+)-(2S,2S)-3[(S)-3-methyl-1-(3-methylbutylcarbamoyl)butylcarbamoyl]-2-oxiranecarboxylate (EST)(report VI) Chronic toxicity study in rats","volume":"17","author":"Ohshima","year":"1986","journal-title":"Iyakuhin Kenkyu"},{"key":"B304","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0041-008X(90)90353-V","article-title":"An epoxysuccinic acid derivative(loxistatin)-induced hepatic injury in rats and hamsters","volume":"105","author":"Fukushima","year":"1990","journal-title":"Toxicol Appl Pharmacol"},{"key":"B305","first-page":"632","article-title":"Reproduction studies of ethyl(+)-(2S,2S)-3[(S)-3-methyl-1-(3-methylbutylcarbamoyl)butylcarbamoyl]-2-oxiranecarboxylate (EST) (report III): study of administration to rabbits during organogenesis","volume":"17","author":"Yamada","year":"1986","journal-title":"Iyakuhin Kenkyu"},{"key":"B306","first-page":"617","article-title":"Reproduction studies of ethyl(+)-(2S,2S)-3[(S)-3-methyl-1-(3-methylbutylcarbamoyl)butylcarbamoyl]-2-oxiranecarboxylate (EST) (report II): study of administration to rats during organogenesis","volume":"14","author":"Yamada","year":"1986","journal-title":"Iyakuhin Kenkyu"},{"key":"B307","first-page":"609","article-title":"Reproduction studies of ethyl(+)-(2S,2S)-3[(S)-3-methyl-1-(3-methylbutylcarbamoyl)butylcarbamoyl]-2-oxiranecarboxylate (EST) (report I): study of administration to rats prior to and in early stage of gestation","volume":"17","author":"Yamada","year":"1986","journal-title":"Iyakuhin Kenkyu"},{"key":"B308","first-page":"639","article-title":"Reproduction studies of ethyl(+)-(2S,2S)-3[(S)-3-methyl-1-(3-methylbutylcarbamoyl)butylcarbamoyl]-2-oxiranecarboxylate (EST) (report IV): study of administration to rats during perinatal and postnatal periods","volume":"17","author":"Yamada","year":"1986","journal-title":"Iyakuhin Kenkyu"},{"key":"B309","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.2174\/156802609789753653","article-title":"The identification, characterization and optimization of small molecule probes of cysteine proteases: experiences of the Penn Center for Molecular Discovery with cathepsin B and cathepsin L","volume":"9","author":"Huryn","year":"2009","journal-title":"Curr Top Med Chem"}],"container-title":["Frontiers in Neurology"],"original-title":[],"deposited":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T13:23:37Z","timestamp":1748611417000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/Article\/10.3389\/fneur.2015.00178\/abstract"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,2]]},"references-count":309,"URL":"https:\/\/doi.org\/10.3389\/fneur.2015.00178","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,2]]}}}